The use of tacrine for tardive dyskinesia.
The authors administered 45-90 mg/day of tacrine to eight patients with tardive dyskinesia. After 2 weeks of treatment, there was a mean reduction in tardive dyskinesia scores of 43%. No improvement occurred when a placebo was used instead of tacrine.
D000284:Administration, Oral; D000328:Adult; D000609:Aminoacridines / Q000627:therapeutic use*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013619:Tacrine / Q000008:administration & dosage / Q000627:therapeutic use*
D000609:Aminoacridines; D013619:Tacrine